Leading Biotech & Healthcare Hedge Funds manage nearly $100 Billion; Gainers accumulate $5.2 Billion

February 2nd, 2015
| More
The most recent rankings for the Top 75 Healthcare, Pharma and Biotech Focused Hedge Fund list reveal that the top funds now manage $98.5 billion in U.S. equity assets.

43% of the hedge funds on the list saw their assets increase over the third quarter, adding $5.2 billion in assets under management. Leading the top gainers were Glenview Capital Management, Pershing Square Capital Management and OrbiMed Advisors

Glenview Capital’s asset gains enabled Larry Robbins’ hedge fund to reclaim the top spot on the the Top Healthcare, Pharma and Biotech Hedge Fund List from Andreas Halvorsen’s Viking Global. Greenwich-based Viking Global fell off the list, after having trimmed its healthcare sector allocation to just 24%.

Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings, along with their Key Decision Makers, are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.
For Detailed Investor Profiles on these Investors, click below:
Glenview Capital Management
OrbiMed Advisors
Related People: Larry Robbins; Samuel Isaly
Related Entities: Caduceus Asia Partners LP; Caduceus Capital LP; Eaton Vance Worldwide Health Sciences; Finsbury Worldwide Pharmaceutical; GCM Little Arbor Institutional Partners; GCM Little Arbor Master; GCM Little Arbor Partners; Glenview Capital Master; Glenview Capital Partners; Glenview Institutional Partners; OrbiMed Associates; OrbiMed Capital
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News; Featured Reports

More Recent Headlines

California edges out Connecticut, Massachusetts and Illinois, claiming #2 spot on the Top States for Hedge Funds List

The New CEO Activist Hedge Fund Makes No Sense

DE Shaw, Citadel and Lone Pine largest Consumer Discretionary hedge fund investors

Top Hedge Funds retain strong allocations to Energy Sector: Citadel and Icahn named largest Energy sector investors

Mark Carhart flies, Paul Tudor Jones limps, and John Paulson tumbles

SAC Capital and Highfields veterans finalize $1 billion launch plans for Folger Hill Asset Management

Douglas L. Braunstein and James C. Woolery launch Hudson Executive Capital

Thanks to a White Knight, Bill Ackman’s Allergan activist campaign ends with $2.5 billion profit

Top Activist Hedge Funds close in on $200 billion mark; ValueAct Capital, Elliott Management & JANA Partners lead the way

Chicago and Texas hedge funds dominate the Top Central U.S. Hedge Fund List